Contera Pharma A/S
Health Care · Biotechnology
Clinical trials: 3No open roles listed
Data updated Nov 21, 2026Full reportReport a mistake
Facts
as of Nov 21, 2026AboutContera Pharma Learn about us Foundation and core beliefs Our Ambition Neurological disorders are devastating and complex conditions with limited treatment options.
- Employees
- 201-500estimated range
- Website
- conterapharma.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Products
Products →Contera Pharma A/S has 3 clinical trials on record, 0 under way.
Clinical trials
Open-Label Extension Study of ASTORIA
phase 2 · stopped or withdrawn · 6 participants · Dyskinesias
Jan 2024
A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
phase 2 · completed · 89 participants · Dyskinesias
Jul 2019
Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia
phase 2 · completed · 30 participants · as a collaborator · Parkinson's Disease; Levodopa Induced Dyskinesia (LID)
May 2015
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
